LIVMARLI showed maintenance of treatment effect with sustained decrease in serum...
GRIA disorder is a family of rare genetic diseases triggered by mutations in the...
Everest’s NDA for Nefecon in China is anticipated to receive clearance by the se...
Biotheryx will receive up to $347m in potential future regulatory and commercial...
Shanghai Henlius Biotech, Accord’s business partner, originally developed HLX02.
After more than a decade, the FDA has updated its guidance for patient-focused d...
The UK’s MHRA gave a green light to the company to start a Phase IIb trial with ...
The Biden administration will soon crack down on Medicare Advantage insurers tha...
Three former executives at Magellan Diagnostics are charged with knowingly selli...
For cancer patients, global supply chain issues can mean the difference between ...
J&J said it agreed to settle claims from tens of thousands of people who say its...
For years, there has been relatively little attention paid to CMV, a common infe...
A study of pregnant women suggests that there are better ways than BMI to assess...
It's important to better connect the health care ecosystem so that we more effec...
"What Mark Cuban and his team have done is true disruption, and is terrific for ...
In the latest edition of STAT's Health Tech newsletter: using devices to help ca...
